Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers

被引:53
|
作者
Singh, Krishna [1 ]
Lester, Jenny [2 ]
Karlan, Beth [2 ]
Bresee, Catherine [2 ]
Geva, Tali [1 ]
Gordon, Ora [1 ]
机构
[1] Cedars Sinai Med Ctr, Cedars Sinai Med Genet Inst, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA
关键词
BRCA mutations; family history; prophylactic mastectomy; prophylactic salpingo-oophorectomy; SALPINGO-OOPHORECTOMY; OVARIAN-CANCER; BREAST; WOMEN; TIME;
D O I
10.1016/j.ajog.2013.01.026
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Despite substantial survival benefits of risk-reducing mastectomy (RRM) and risk-reducing bilateral salpingo-oophorectomy (RRBSO) among BRCA mutation carriers, only a minority elect to undergo these procedures. This study investigates factors that might influence decision making regarding prophylactic surgeries among women with BRCA mutations. STUDY DESIGN: Unaffected BRCA mutation carriers who were counseled at our center and either underwent prophylactic surgery or participated in a high-risk surveillance program at our institution from 1998 through 2010 were included in the study. Medical records were reviewed and data collected included age, family history, parity, mutation type, history of breast biopsy or cosmetic surgery, and uptake of prophylactic surgeries. RESULTS: Among 136 unaffected women with BRCA mutations, uptake of RRM was 42% and uptake of RRBSO was 52%. Family history of first- and second-degree relatives being deceased from breast cancer was predictive of uptake of RRM and of RRBSO (odds ratio [OR], 11.0; P = .005; and OR, 15.8; P = .023, respectively), and history of a mother lost to pelvic cancer was predictive of uptake of RRBSO (OR, 7.9; P = .001). Parity also predicted both RRM and RRBSO uptake (OR, 4.2; P = .001; and OR, 5.4; P = .003, respectively). Age at the time of genetic testing and history of breast biopsy or cosmetic surgery were not predictive of RRM uptake. CONCLUSION: Perceptions of cancer risk are heavily influenced by particular features of an individual's family history and may be motivators in preventive surgery more than actual cancer risk estimations themselves. Awareness of subtle factors beyond the statistical risk for cancers is relevant when counseling at-risk women.
引用
收藏
页码:329.e1 / 329.e6
页数:6
相关论文
共 50 条
  • [31] The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication
    Alves-Nogueira, Ana C.
    Melo, Daniela
    Carona, Carlos
    Figueiredo-Dias, Margarida
    CURRENT ONCOLOGY, 2023, 30 (02) : 2429 - 2440
  • [32] Risk-reducing mastectomy in mutation carriers
    Zaborowski, Alexandra M.
    Boland, Michael R.
    BRITISH JOURNAL OF SURGERY, 2024, 111 (10)
  • [33] Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy
    Chan, Jessica L.
    Senapati, Suneeta
    Johnson, Lauren N. C.
    DiGiovanni, Laura
    Voong, Chan
    Butts, Samantha F.
    Domchek, Susan M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (02): : 132 - 139
  • [34] Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status
    Manchanda, R.
    Abdelraheim, A.
    Johnson, M.
    Rosenthal, A. N.
    Benjamin, E.
    Brunell, C.
    Burnell, M.
    Side, L.
    Gessler, S.
    Saridogan, E.
    Oram, D.
    Jacobs, I.
    Menon, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (07) : 814 - 824
  • [35] Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers
    Lee, Sarah S.
    Karpel, Hannah C.
    Oh, Cheongeun
    Smith, Julia
    Pothuri, Bhavana
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 234 - 240
  • [36] Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers
    Chai, Xinglei
    Friebel, Tara M.
    Singer, Christian F.
    Evans, D. Gareth
    Lynch, Henry T.
    Isaacs, Claudine
    Garber, Judy E.
    Neuhausen, Susan L.
    Matloff, Ellen
    Eeles, Rosalind
    Tung, Nadine
    Weitzel, Jeffrey N.
    Couch, Fergus J.
    Hulick, Peter J.
    Ganz, Patricia A.
    Daly, Mary B.
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Blum, Joanne L.
    Domchek, Susan M.
    Chen, Jinbo
    Rebbeck, Timothy R.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (02) : 397 - 406
  • [37] Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier
    Maeshima, Yurina
    Oseto, Kumiko
    Katsuragi, Ryohei
    Yoshimoto, Yukiko
    Takahara, Sachiko
    Yamauchi, Akira
    JOURNAL OF BREAST CANCER, 2016, 19 (02) : 218 - 221
  • [38] Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
    B. E. Kiely
    M. L. Friedlander
    R. L. Milne
    L. Stanhope
    P. Russell
    M. A. Jenkins
    P. Weideman
    S. A. McLachlan
    P. Grant
    J. L. Hopper
    K. A. Phillips
    Familial Cancer, 2011, 10 : 505 - 514
  • [39] Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea
    Se Ik Kim
    Myong Cheol Lim
    Dong Ock Lee
    Sun-Young Kong
    Sang-Soo Seo
    Sokbom Kang
    Eun Sook Lee
    Sang-Yoon Park
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 333 - 340
  • [40] Uptake of Risk-Reducing Salpingo-Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers
    Inzoli, Alessandra
    Negri, Serena
    Dell'Oro, Cristina
    Costa, Clarissa
    Marchetta, Liliana
    Boccadutri, Mariaclara
    Fumagalli, Simona
    Roversi, Gaia
    Sala, Elena Maria
    Celi, Chiara
    Rossi, Valentina
    Fruscio, Robert
    CANCER MEDICINE, 2024, 13 (23):